Skip to main content

Animations

MJFF Publications

5531 - 5540 of 6560 Results
Title
Year
  • Year
  • 2025
  • 2026
  • 2026
  • 2026
  • 2026
  • 2026
  • 2026
  • 2025
  • 2024
  • 2026
  • Summary Details
    OPEN
    Title: Impact of Y chromosome loss on the risk of Parkinson's disease and progression
    Journal Name: eBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2025.105769
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Regulator of G protein signaling 10: a critical regulator of chronic systemic inflammation in parkinson’s disease
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-026-03858-4
    Citation Count: 0
  • Summary Details
    OPEN
    Title: The PET tracer [ 11 C]MODAG-005 targets alpha-synuclein aggregates in the brain
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aec0813
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Inter-assay and Inter-site Performance of Alpha-Synuclein Seed Amplification Assays in Synucleinopathies: A Multicenter 2 × 2 Protocol Comparison
    Journal Name: Neurology and Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s40120-026-00965-5
    Citation Count: 0
  • Summary Details
    OPEN
    Title: The GBA1 p. E427K (p. E388K ) Variant Is a Risk Factor for Synucleinopathies: A Meta‐Analysis
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.70367
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Progressive Supranuclear Palsy in India: Insights from a Large Multicenter Clinical Cohort (Project PAIR ‐ PSP )
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.70672
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Longitudinal Repeatome Remodeling in Peripheral Blood Following Parkinson’s Disease Diagnosis
    Journal Name: Genes
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/genes17050577
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Diagnostic and other biomarkers of dementia with Lewy bodies: from research to clinical settings
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(25)00314-x
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Clinical and genetic delineation of autosomal recessive and dominant ACTL6B-related developmental brain disorders
    Journal Name: Genetics in Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.gim.2024.101251
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Cellularized, needle-deployed intracortical arrays for brain electrophysiology
    Journal Name: MRS Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1557/s43579-026-01033-7
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.